Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.
ncRNA
NR2F1-AS1
Specific or universal ncRNAs
Specific ncRNAs
Class
Long non-coding RNA
Biomarker
Yes
Biomarker application
Treatment
Upstream regulatory factor
Not available
Downstream target
Not available
Differential expression in
recurrence vs. nonrecurrence
Up
Cancer name
ER Positive Breast cancers
Alias
Breast cancers
Cancer site
Breast
Recurrence type
Recurrence
Overall survival rate of patients with
high ncRNA expression
Down
ncRNA differential expression in
cancer
patients vs. health people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
Recurrence patients
Not available
Recurrence patients male:female
Not available
Recurrence patients age range
Not available
Recurrence mean age
Not available
Sites of recurrence
Not available
Patients without recurrence
Not available
Patients without recurrence male:female
Patients without recurrence age range
Not available
Patients without recurrence mean age
Not available
PMID
Description
Our findings implicated NR2F1-S1 in the dynamics of tumor recurrence in ER positive breast cancers and introduce a new biomarker that holds a therapeutic potential, providing favorable prospects to be translated into the clinical field.
Tissue resource
clinical specimens from luminal breast cancer patients
Experiment
qRT-PCR,Western blot, Microarray analysis
Institute
National Cancer Center Hospital
Country
Japan
Continent
Asia
Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.